A detailed history of Twinbeech Capital LP transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Twinbeech Capital LP holds 105,682 shares of VKTX stock, worth $5.45 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
105,682
Holding current value
$5.45 Million
% of portfolio
0.13%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$49.84 - $70.47 $5.27 Million - $7.45 Million
105,682 New
105,682 $6.69 Million
Q4 2023

Feb 14, 2024

SELL
$9.24 - $19.64 $1.23 Million - $2.62 Million
-133,586 Reduced 62.85%
78,947 $1.47 Million
Q3 2023

Nov 14, 2023

BUY
$10.92 - $16.0 $2.32 Million - $3.4 Million
212,533 New
212,533 $2.35 Million

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $3.95B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Twinbeech Capital LP Portfolio

Follow Twinbeech Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Twinbeech Capital LP with notifications on news.